Preparing a patient for a suspected cancer referral

Latest from the Blog

Meet the specialists: lung cancer vs COVID-19 Q&A

Meet the specialists: lung cancer vs COVID-19 Q&A

Friday 30th October 2020 Missed our free GatewayC webinar on Lung Cancer vs COVID-19? Watch our recording here. In this webinar GatewayC met Dr Matthew Evison, Consultant Chest Physician and Director of the Lung Pathway Board, and Dr Seamus Grundy, Consultant...

read more
Meet the specialists: acute leukaemia Q&A

Meet the specialists: acute leukaemia Q&A

Friday 23rd October 2020 Missed our free GatewayC webinar on Acute Leukaemia? Watch our recording here. In this webinar GatewayC met Dr Amit Patel, a Consultant in Cellular Therapies and Stem Cell Transplantation, who answered key questions from our audience. These...

read more

Related Posts

Improve the quality of your referral with GatewayC

Improve the quality of your referral with GatewayC

Friday 25th September 2020 Are you seeking to improve your suspected cancer referrals? Our Improving the Quality of Your Referral course aims to assist you with this and covers: Clinical decision making Helping to reduce DNAs Key information to include in a referral...

read more
World Lymphoma Awareness Day

World Lymphoma Awareness Day

Tuesday 15th September 2020 It’s World Lymphoma Awareness Day. Why not increase your knowledge and complete our free online Lymphoma – Early Diagnosis course supported by Lymphoma Action? Lymphoma has many non-site specific symptoms and patients can often visit...

read more

Up to 1 in 10 patients do not attend their two week wait appointment, with some patients not understanding the seriousness of the referral. This statistic shows how important it is for GPs to share their concerns around the possibility of cancer, but knowing what to say can be difficult.

Should GPs share their concerns?

Dr Richard Roope, RCGP National Cancer Champion and CRUK Senior Clinical Advisor, advises some patients are grateful to be told they’re being referred to exclude the possibility of cancer. A recent patient survey* from Macmillan Cancer Support supports this view; 90% of respondents felt that every patient who is referred under a 2 week wait should be told that this could mean a possible cancer diagnosis.

Patients that may not be fully prepared for a potential cancer diagnosis may fail to prioritise their appointment accordingly which could result in non-attendance, or face a difficult result whilst on a short break from work, or attending without support from a friend or family member.

The GatewayC ‘Improving the quality of your referral’ course refreshes your knowledge on how to best prepare a patient who is being referred on a suspected cancer pathway, from both a clinical and patient perspective. The course also covers both the consequences of poor preparation of a patient in comparison with good patient preparation.

 

Positive predicted value

The positive predicted value (PPV) is the likelihood that a patient with a collection of symptoms will then go on to be diagnosed with cancer. GPs have a minimum value set at 3% which means that for every 100 patients with a particular set of symptoms, a minimum of 3 of those patients will be diagnosed with cancer. However, this can fluctuate depending on the set of symptom clusters.

“I find that patients respond very well to being told what their PPV is. For example, it might be a 5-10% chance of having cancer, but likewise it’s a 95-90% chance of them not having cancer.” – Dr Richard Roope, RCGP National Cancer Champion and CRUK Senior Clinical Advisor.

Cancer Key:

It is important to ensure your patient fully understands the nature of their referral to make sure they attend and they are prepared. One helpful way to put this information into context for patients that are concerned may be to underline the PPV of a cancer diagnosis.

Find out more: visit the GatewayC Improving the quality of your referral course here.

Keep up to date: Twitter | Facebook | LinkedIn

* Information from Macmillan Cancer Support Two Week Wait Survey, November 2018

Latest from the Blog

Meet the specialists: lung cancer vs COVID-19 Q&A

Meet the specialists: lung cancer vs COVID-19 Q&A

Friday 30th October 2020 Missed our free GatewayC webinar on Lung Cancer vs COVID-19? Watch our recording here. In this webinar GatewayC met Dr Matthew Evison, Consultant Chest Physician and Director of the Lung Pathway Board, and Dr Seamus Grundy, Consultant...

read more
Meet the specialists: acute leukaemia Q&A

Meet the specialists: acute leukaemia Q&A

Friday 23rd October 2020 Missed our free GatewayC webinar on Acute Leukaemia? Watch our recording here. In this webinar GatewayC met Dr Amit Patel, a Consultant in Cellular Therapies and Stem Cell Transplantation, who answered key questions from our audience. These...

read more

Related Posts

Improve the quality of your referral with GatewayC

Improve the quality of your referral with GatewayC

Friday 25th September 2020 Are you seeking to improve your suspected cancer referrals? Our Improving the Quality of Your Referral course aims to assist you with this and covers: Clinical decision making Helping to reduce DNAs Key information to include in a referral...

read more
World Lymphoma Awareness Day

World Lymphoma Awareness Day

Tuesday 15th September 2020 It’s World Lymphoma Awareness Day. Why not increase your knowledge and complete our free online Lymphoma – Early Diagnosis course supported by Lymphoma Action? Lymphoma has many non-site specific symptoms and patients can often visit...

read more